Literature DB >> 16181731

The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis.

Vassiliki A Papadimitrakopoulou1, Erika N Brown, Diane D Liu, Adel K El-Naggar, J Jack Lee, Waun Ki Hong, Ho-Young Lee.   

Abstract

The activities of insulin-like growth factors (IGFs) in regulating cell proliferation, differentiation, and apoptosis are modulated by a family of high-affinity specific IGF-binding proteins (IGFBPs), IGFBP-3 being the most abundant in circulation. Down-regulation of IGFBP-3 has been shown to be associated with a shorter disease-specific survival probability in early non-small-cell lung cancer (NSCLC). We examined the prognostic role of IGFBP-3 protein expression loss in 34 squamous cell carcinomas (SCC) of the tongue (stages II-IV) and 30 premalignant lesions of the oral cavity and the larynx. Reduced IGFBP-3 expression was found in 11 (32%) of 34 tongue SCC cases, and was associated with significantly shorter disease-specific and disease-free survival (P=0.0002 and <0.0001 by Log-rank test). In premalignant lesions, IGFBP3 loss was found in 8 (27%) of 30 cases without significant association with cancer-free survival. Therefore, down-regulation of IGFBP-3 is an early event during head and neck carcinogenesis, that bears an adverse prognostic significance in tongue cancer and could serve as both a marker of aggressive disease and target for intervention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181731     DOI: 10.1016/j.canlet.2005.08.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

Review 1.  Molecular pathways of lymphangiogenesis and lymph node metastasis in head and neck cancer.

Authors:  A D Karatzanis; E Koudounarakis; I Papadakis; G Velegrakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-21       Impact factor: 2.503

Review 2.  Targeting insulin-like growth factor type 1 receptor in cancer therapy.

Authors:  Francesco Atzori; Tiffany A Traina; Maria Teresa Ionta; Bruno Massidda
Journal:  Target Oncol       Date:  2009-10-30       Impact factor: 4.493

Review 3.  [Advances in molecular mechanisms of bone invasion by oral cancer].

Authors:  Wei Liu; Chun-Jie Li; Long-Jiang Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-04-01

4.  A multiplicity of anti-invasive effects of farnesyl transferase inhibitor SCH66336 in human head and neck cancer.

Authors:  Seung Hyun Oh; Ju-Hee Kang; Jong Kyu Woo; Ok-Hee Lee; Edward S Kim; Ho-Young Lee
Journal:  Int J Cancer       Date:  2012-01-31       Impact factor: 7.396

5.  High-yield bacterial expression and structural characterization of recombinant human insulin-like growth factor binding protein-2.

Authors:  Monalisa Swain; Mark G Slomiany; Steven A Rosenzweig; Hanudatta S Atreya
Journal:  Arch Biochem Biophys       Date:  2010-06-10       Impact factor: 4.013

6.  Clinicopathological significance and impact on outcomes of the gene expression levels of IGF-1, IGF-2 and IGF-1R, IGFBP-3 in patients with colorectal cancer: Overexpression of the IGFBP-3 gene is an effective predictor of outcomes in patients with colorectal cancer.

Authors:  Naoto Yamamoto; Takashi Oshima; Kazue Yoshihara; Toru Aoyama; Tsutomu Hayashi; Takanobu Yamada; Tsutomu Sato; Manabu Shiozawa; Takaki Yoshikawa; Soichiro Morinaga; Yasushi Rino; Chikara Kunisaki; Katsuaki Tanaka; Makoto Akaike; Toshio Imada; Munetaka Masuda
Journal:  Oncol Lett       Date:  2017-03-28       Impact factor: 2.967

7.  Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.

Authors:  Jin-Soo Kim; Edward S Kim; Diane Liu; J Jack Lee; Luisa Solis; Carmen Behrens; Scott M Lippman; Waun Ki Hong; Ignacio I Wistuba; Ho-Young Lee
Journal:  Clin Lung Cancer       Date:  2014-01-01       Impact factor: 4.785

8.  IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment.

Authors:  Mitsuteru Natsuizaka; Hideaki Kinugasa; Shingo Kagawa; Kelly A Whelan; Seiji Naganuma; Harry Subramanian; Sanders Chang; Kei J Nakagawa; Naryan L Rustgi; Yoshiaki Kita; Shoji Natsugoe; Devraj Basu; Phyllis A Gimotty; Andres J Klein-Szanto; J Alan Diehl; Hiroshi Nakagawa
Journal:  Am J Cancer Res       Date:  2014-01-15       Impact factor: 6.166

9.  Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions.

Authors:  Robert C Baxter
Journal:  J Cell Commun Signal       Date:  2013-08       Impact factor: 5.782

10.  A novel antitumor activity of deguelin targeting the insulin-like growth factor (IGF) receptor pathway via up-regulation of IGF-binding protein-3 expression in breast cancer.

Authors:  Young-Ah Suh; Jai-Hyun Kim; Myung A Sung; Hye-Jin Boo; Hye Jeong Yun; Sun-Hye Lee; Hyo-Jong Lee; Hye-Young Min; Young-Ger Suh; Kyu-Won Kim; Ho-Young Lee
Journal:  Cancer Lett       Date:  2013-01-21       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.